2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow TP protocol: new trials by email Literature Review of TP protocol trials Research Report on TP protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006) Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy - Esophagus Cancer | Phase 2 | Active not recruiting | Sun Yat-sen University | 46 | 2024-03-02 | 2026-04-23 |
| Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) Paclitaxel, Cisplatin, tislelizumab, Radiotherapy - Esophageal Squamous Cell Carcinoma, Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | Active not recruiting | Sun Yat-sen University | 114 | 2022-09-15 | 2024-11-18 |
Esophageal Squamous Cell Carcinoma (2) · Esophageal Neoplasms (1)
China (2)
Mian Xi, MD (1) · Ruihua Xu, MD (1)
PMID 34454674, PMID 34519801, PMID 35108470, PMID 36990609, PMID 37797632, PMID 37852261, PMID 41962116